- Country: Ukraine
- Summary: Diphenhydramine Solution for Injection, 10 Mg/Ml in 1 Ml Ampoule (Diphenhydramine); Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 5 Ml each (Magnesium Sulfate); Dexamethasone, Solution for Injection 4Mg/Ml (Dexame...
- UAT Ref No: 130259372
- Deadline: 17 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 31293
- Notice Type: Tender
- Document Ref. No.: UA-2025-11-12-008529-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Diphenhydramine solution for injection, 10 mg/ml in 1 ml ampoule (Diphenhydramine); Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each (Magnesium sulfate); Dexamethasone, solution for injection 4mg/ml (Dexamethasone); Metoclopramide, solution for injection, 5 mg/ml, 2 each ml (Metoclopramide); Sodium chloride, solution for infusions, 9 mg/ml 200 ml (Sodium chloride); Sodium chloride, solution for injection, 9 mg/ml, 5 ml each (Sodium chloride); Papaverine, solution for injection, 20 mg/ml, 2 ml each (Papaverine); Furosemide, solution for injection, 10 mg/ml, 2 ml each (Furosemide); Normopress tablets (Captopril and diuretics); RENALGAN® solution for injections of 5 ml in an ampoule (Pitofenone and analgesics); Ethyl alcohol 70% 100 ml (Ethanol); Ammonia, solution for external use, 10%, 40 ml each (Ammonia) Purchase type: goods. Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products. Term (term) of product delivery: during 2025, according to the Customer's applications. The goods will be delivered in the declared quantity no later than the 5th working day from the moment of receipt of a written application from the Customer to the Supplier's e-mail address, but no later than December 15, 2025. Product price: the Participant determines the price of the product taking into account the cost of the product itself, taxes and fees that payable or payable, transportation costs, str... Other Name Classifier and its corresponding code Quantity/Unit of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Term (term) of product delivery: during 2025, in accordance with the Customer's applications. The goods will be delivered in the declared quantity no later than the 5th working day from the moment of receipt of the written request from the Customer to the Supplier's email address, but no later than December 15, 2025. Product price: The participant determines the price of the product...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDiphenhydramine Solution for Injection, 10 Mg/Ml in 1 Ml Ampoule (Diphenhydramine); Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 5 Ml each (Magnesium Sulfate); Dexamethasone, Solution for Injection 4Mg/Ml (Dexame... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE OF BILOTSERKIV CITY COUNCIL "MUNICIPAL CENTER OF PRIMARY MEDICAL AND SANITARY AID #1", a Government sector organization in Ukraine, has announced a new tender for Diphenhydramine Solution for Injection, 10 Mg/Ml in 1 Ml Ampoule (Diphenhydramine); Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 5 Ml each (Magnesium Sulfate); Dexamethasone, Solution for Injection 4Mg/Ml (Dexame.... This tender is published on UkraineTenders under UAT Ref No: 130259372 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-17.
The estimated tender value is UAH 31293, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
